ABT-894

ABT-894 · Abbott

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABT-894, covering 2010-11-02 to 2010-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]

See pricing